Fundraising FoxPBM Capital
Venture capitalCharlottesville · Seed–Late Stage · 6 people tracked
Find your way into PBM Capital
Each arrow is one introduction. Sign up to fill in the first one.
Ask Carol Reed to introduce you to Jayson Rieger
Ask Sam Okafor to introduce you to Sean Stalfort
Ask Riley Novak to introduce you to Paul B. Manning
- Dave Zawitz1 person can intro you
Sign up to find every way you can get introduced to PBM Capital
- Your email: who you already know at PBM Capital, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the PBM Capital team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
PBM Capital partners with scientists and entrepreneurs to build long-term value in life sciences and healthcare companies. The firm supplies capital at critical stages of company development while applying deep industry knowledge, strategic relationships, and hands-on operational experience. Its portfolio emphasizes companies developing life-changing therapies and products with meaningful real-world impact.
Source: firm website, verified Aug 3, 2026.
Team · 6 people
from the firm's website
What they invest in
from 7 of 7 portfolio companiesBiotech ×6Healthtech ×3Medical Devices ×2Deep Tech ×1Digital Health ×1
HQs:United States×7
Investments · 7 tracked
founders shown can be your intro pathBy year:2025 · 12022 · 12021 · 22020 · 12016 · 12015 · 17 dated
Liquidia develops and commercializes inhaled and injectable therapies for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.
BiotechMorrisville, US
Damian deGoa(Executive Officer, Director)inMichael Kaseta(Executive Officer)in
BoardStephen Bloch(Director)inJoanna Horobin(Director)Raman Singh(Director)
Board seatPaul B. Manning· per SEC Form D · $21.7M raise · filed Apr 2021
Co-investorsCanaan PartnersNew Enterprise Associates (NEA)Xeraya Capital
Taysha Gene Therapies develops and commercializes gene therapies for monogenic diseases of the central nervous system, serving patients with rare and larger CNS conditions.
BiotechDeep TechDigital HealthHealthtechMedical DevicesTexas, US
R.A. Session II(Executive Officer, Director)inSean P. Nolan(Chief Executive Officer and Board Chairman)in
Board seatPaul B. Manning· per SEC Form D · $30M raise · filed Nov 2022
Co-investorsGV (Google Ventures)BairdGoldman SachsJefferies
Verrica Pharmaceuticals is a therapeutics company developing and commercializing treatments for dermatological diseases, including molluscum contagiosum, common warts, and skin cancers such as basal cell and squamous cell carcinoma.
BiotechHealthtechMedical DevicesWest Chester, US
Noah Rosenberg(Executive Officer)inJohn Kirby(Executive Officer)Matthew Davidson(Executive Officer, Director)
BoardDavid Zawitz(Executive Officer)
Board seatPaul B. ManningJayson Rieger· per SEC Form D
Co-investorsOrbiMed
HealthtechBoulder, US
Jason Myers(Executive Officer, Director)Christian LaPointe(Executive Officer)
BoardKyle Lefkoff(Director)inPaul Manning(Director)in
Board seatPaul B. Manning· per SEC Form D
Co-investorsCrawley VenturesBoulder VenturesLongwood FundREDMILESands Capital VenturesSoleus Capital
BiotechCharlottesville, US
Raymond Chavez(Executive Officer, Director)inStephen Collins(Executive Officer, Director)inLinda Watkins(Director)
BoardPeter Heinecke(Director)John Forsayeth(Director)
Board seatPaul B. ManningJayson Rieger· per SEC Form D · $30M raise · filed Jun 2021
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 3
3 IPOsLiquidia CorporationNASDAQ: LQDATaysha Gene TherapiesNASDAQ: TSHAVerricaNASDAQ: VRCA
Portfolio news
latest coverage across their companiesVerrica · verrica.com · Jul 30, 2026
Frequently asked questions
- How many investments has PBM Capital made?
- PBM Capital has 7 tracked investments, 3 of which have exited, including 1 dated in the last 24 months.
- What stage does PBM Capital invest at?
- PBM Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does PBM Capital focus on?
- PBM Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is PBM Capital located?
- PBM Capital is headquartered in Charlottesville, US.
- Who does PBM Capital co-invest with?
- PBM Capital most often shares deals with Foresite Capital, OrbiMed, RA Capital, among 4 tracked co-investors.
Similar investors
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Sofinnova is an investment firm focused on the life sciences and biotechnology sector, partnering with companies from inception through drug development, regulatory approval, company building, and IPO.
RiverVest Venture Partners is a life sciences venture capital firm that invests in biotechnology and medical companies, working with entrepreneurs to advance therapeutic and medical innovations.
Pitango is an Israel-based venture capital firm that has backed founders across technology sectors for decades, offering portfolio companies access to a broad network of customers, partners, and leaders.